[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@__hand_banana Avatar @__hand_banana Hand Banana

Hand Banana posts on X about made me, contracts, you dont, bytedance the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence finance XXXX% technology brands XXXX%

Social topic influence made me 7.14%, contracts 7.14%, you dont 7.14%, bytedance 7.14%, strikes 7.14%, layoffs XXXX%

Top accounts mentioned or mentioned by @gigafelon @usgraphics @telmudic @thanksthoth @nearcyan

Top Social Posts #


Top posts by engagements in the last XX hours

"@telmudic are we talking Restoration Hardware or Design Within Reach"
X Link @__hand_banana 2025-10-25T04:29Z 1013 followers, 1362 engagements

"patents exist almost entirely as a legal cudgel with which to abuse your competitors. the world is not enriched by Amazon disclosing their "one-click to buy" technology in a patent"
X Link @__hand_banana 2025-10-28T18:34Z 1013 followers, XXX engagements

"@gigafelon to the best of my knowledge yeah. although coming up with real-world use-cases for vgf2p8affineqb is a party trick every SIMD person eventually learns"
X Link @__hand_banana 2025-10-30T02:16Z 1013 followers, XX engagements

"@ThanksThoth get some car loans and credit you don't plan on repaying"
X Link @__hand_banana 2025-10-26T00:21Z 1014 followers, XXX engagements

"@nearcyan sv's opinion re. gambling for kids doesn't really matter. bytedance and EA and T2 are all outside sv and have been mastering that shit for ages"
X Link @__hand_banana 2025-10-28T14:55Z 1015 followers, XXX engagements

"even in pharma patents do not stop your competitors from making substantially similar drugs to yours (see for example the proliferation of GLP-1 agonists). the moat is the huge regulatory hurdle for not-quite-identical stuff"
X Link @__hand_banana 2025-10-28T18:36Z 1014 followers, XX engagements

"Yup. The area under the curve here hasn't zeroed yet"
X Link @__hand_banana 2025-10-30T04:03Z 1014 followers, XXX engagements